Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery Patients.

Journal: HSS journal : the musculoskeletal journal of Hospital for Special Surgery
Published Date:

Abstract

BACKGROUND: Orthopedic patients are at risk for adverse postoperative cardiovascular outcomes.

Authors

  • Anne R Bass
    1Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021 USA.
  • Jackie D Szymonifka
    1Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021 USA.
  • Matthew T Rondina
    Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City.
  • Margaret Bogardus
    3Columbia University College of Physicians & Surgeons, New York City, NY USA.
  • Mitchell G Scott
    4Washington University School of Medicine, St. Louis, MO USA.
  • Scott C Woller
    5Intermountain Healthcare, Murray, UT USA.
  • Scott M Stevens
    5Intermountain Healthcare, Murray, UT USA.
  • Charles Eby
    4Washington University School of Medicine, St. Louis, MO USA.
  • Kerri Merritt
    1Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021 USA.
  • Alejandro Gonzalez Della Valle
    1Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021 USA.
  • Gerard Moskowitz
    4Washington University School of Medicine, St. Louis, MO USA.
  • Eva Flores
    6New York Presbyterian Hospital, New York City, NY USA.
  • Brian F Gage
    4Washington University School of Medicine, St. Louis, MO USA.

Keywords

No keywords available for this article.